Loading
NC
Neogen Corp Stock: price and insider trades · United States
1 insider bought €9,169 of shares over the last 90 days, the latest filed 09 Oct 2026.
Neogen Corp: what insiders have been doing
Neogen Corp, classified in the Healthcare & Pharma sector, is a listed company based in Anderlecht, Belgium, founded in 1981. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 18 October 2026, brought 49 filings signed by 21 insiders.
Every open-market trade in the period is a purchase: 6 purchases worth €12k, from 1 insider, and not a single sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 1 chief executive. At €5,375, the purchase published on 9 October 2026 by Nassif Mikheal is the largest of the period (0.0002% of market cap).
For context, the typical company on the same exchange (median of 5,808 companies) published 19 filings over the same period, against 49 filings here. Over the whole record (from 2016), the tally stands at 41 purchases and 9 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 May 2026 lists revenue at 870.4 m USD and net income at -7.9 m USD.
The latest purchase is recent: it was published 9 days ago, on 9 October 2026. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade.
For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
188
Thresholds
n/a
Buy Volume
€4M
41 ops. · all time
Sell Volume
€130,663
9 ops. · all time
Who traded when
BuySaleMikheal Nassif6 buys
James C. Borel2 buys
Aashima Gupta1 buy
Adent John Edward1 buy
Boehm William T1 buy
Catherine E. Woteki1 buy
+6 other insiders
Since the insiders bought
- +5.8%Entry US$11.47 · Close 14 Oct 2026 US$12.13
- +33.9%Entry US$6.49 · Close at T+365 US$8.69
- +83.9%Entry US$5.14 · Close at T+365 US$9.45
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Neogen Corp Buy (bullish), based on 3 analysts. Average price target: US$14.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,546 of 24,148 companies
33.2
score / 100
Value33
Quality34
FCF yld1.2%
Earn yld-0.3%
EV/EBITDA20.4x
ROE-2.7%
Gross mgn47%
Net mgn-0.9%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended May 2026 · cache
US$12.00
Analyst consensus
3 analystsBuy
US$14.00Target US$14.00(+17%)US$14.00
Income statement
RevenueUS$870.4M
Gross profitUS$408.5M47% margin
EBITDAUS$170.5M20% margin
Net income-US$7.9M-6.3% margin
Valuation
PER (forward)29.8x
P/Book1.2x
Beta1.79
Balance sheet & cash
Market capUS$2.6B
Total debtUS$793.7M
Free Cash FlowUS$31.9M
Debt / Equity37%
Profitability & ownership
ROE-2.7%
ROA-0.1%
% insiders0.7%
% institutions110.9%
Last declaration on 9 October 2026
Declarations188 total
505 shares@ US$11.950.0002% mcap0.2% of flowCommon StockSEC:0000711377-26-000029:0
Canonical exit: 7 Jan 2027 (T+90)
9,804 shares@ US$12.240.0043% mcap27.7% of flowRestricted Stock UnitsSEC:0000711377-26-000028:0
9,804 shares@ US$12.240.0043% mcap23.5% of flowRestricted Stock UnitsSEC:0000711377-26-000023:0
9,804 shares@ US$12.240.0043% mcap50.6% of flowRestricted Stock UnitsSEC:0000711377-26-000025:0
9,804 shares@ US$12.240.0043% mcap23.3% of flowRestricted Stock UnitsSEC:0000711377-26-000022:0
9,804 shares@ US$12.240.0043% mcap12.0% of flowRestricted Stock UnitsSEC:0000711377-26-000021:0
9,804 shares@ US$12.240.0043% mcap23.7% of flowRestricted Stock UnitsSEC:0000711377-26-000024:0
9,804 shares@ US$12.240.0043% mcap44.2% of flowRestricted Stock UnitsSEC:0000711377-26-000027:0
9,804 shares@ US$12.240.0043% mcap27.4% of flowRestricted Stock UnitsSEC:0000711377-26-000026:0
2,365 shares@ US$11.870.0009% mcap4.9% of flowRestricted Stock UnitsSEC:0000711377-26-000020:0
20,397 shares@ US$11.870.0080% mcap8.4% of flowRestricted Stock UnitsSEC:0000711377-26-000019:0
38,627 shares@ US$11.650.015% mcap100.0% of flowCommon StockSEC:0000711377-26-000016:0
25,751 shares@ US$11.650.0099% mcap44.8% of flowCommon StockSEC:0000711377-26-000017:0
8,584 shares@ US$11.650.0033% mcap17.5% of flowRestricted Stock UnitsSEC:0000711377-26-000018:0
141,631 shares@ US$11.650.055% mcap57.1% of flowCommon StockSEC:0000711377-26-000014:0
51,502 shares@ US$11.650.020% mcap34.8% of flowCommon StockSEC:0000711377-26-000015:0
370 shares@ US$11.810.0001% mcap0.2% of flowCommon StockSEC:0000711377-26-000013:0
Canonical exit: 2 Nov 2026 (T+90)
30,337 shares@ US$8.78660.012% mcap11.9% of flowCommonSEC144:0001959173-26-004307
23 shares@ US$10.940.0% of flowCommon StockSEC:0000711377-26-000006:0
Canonical exit: 18 May 2026 (T+90)
25 shares@ US$9.8550.0% of flowCommon StockSEC:0000711377-26-000005:0
Canonical exit: 26 Apr 2026 (T+90)
50,813 shares@ US$7.3855.2% of flowCommon StockSEC:0000711377-26-000003:0
137 shares@ US$9.33490.0% of flowCommon SharesSEC:0000711377-26-000001:0
Canonical exit: 16 Apr 2026 (T+90)
12,912 shares@ US$5.982.1% of flowCommon StockSEC:0000711377-25-000077:0
177 shares@ US$6.250.0% of flowCommon SharesSEC:0000711377-25-000076:0
Canonical exit: 1 Feb 2026 (T+90)
178,855 shares@ US$6.2965.2% of flowCommon StockSEC:0000711377-25-000074:0
25 of 188 declarations
About Neogen Corp
Neogen Corp. (ticker: NEOG) is a U.S.-listed company traded on the NASDAQ, operating from Lansing, Michigan, United States. Founded in 1982 out of scientific work linked to Michigan State University, Neogen has grown from a small research-driven startup into a global specialist in food safety and animal safety. The company now serves customers in nearly 40 countries, with a commercial and operational footprint that spans North America, Europe, Latin America, and Asia-Pacific. ([neogen.com](https://www.neogen.com/about/))
Neogen’s business is organized around two core segments: Food Safety and Animal Safety. Food Safety includes solutions used to detect allergens, pathogens, microorganisms, and other contaminants, along with environmental monitoring, microbiology, and rapid testing tools for food processors and laboratories. Animal Safety covers immunoassay reagents and test kits, animal toxicology products, veterinary instruments and consumables, animal care and biosafety products, and genomics services for livestock and companion animals. Key brands include Petrifilm, Clean-Trace, Molecular Detection System, and Reveal. ([neogen.com](https://www.neogen.com/about/))
Read moreShow less
From a competitive standpoint, Neogen occupies a specialized niche in the intersection of diagnostics, biosafety, and quality assurance. Its model benefits from recurring consumables, a broad installed customer base, and rising regulatory demands across the food chain. The company’s customer set ranges from commercial labs to dairy, beef, poultry, and pork operators, reinforcing a relatively defensive demand profile tied to food-chain compliance rather than discretionary spending. ([neogen.com](https://www.neogen.com/about/))
Geographically, Neogen remains anchored in the United States, where its corporate headquarters are located at 620 Lesher Place in Lansing, Michigan. At the same time, it operates manufacturing, administrative, sales, and service sites across multiple regions, including Europe, Canada, Latin America, and Asia-Pacific. The company also notes manufacturing and distribution capabilities in locations such as the U.S., the Netherlands, the U.K., and other international markets, underscoring its global supply-chain reach. ([neogen.com](https://www.neogen.com/4ac3cb/globalassets/pdfs/quarterly-and-annual-forms/fy2025-q4-10k.pdf))
Recent corporate developments have centered on portfolio simplification and balance-sheet repair. Neogen completed the divestiture of its global Cleaners & Disinfectants business to Kersia Group in July 2025 for $130 million in cash at closing, with proceeds intended primarily for debt reduction. The company also completed a refinancing of its term loan and revolving credit facility in April 2025, lowering borrowing spreads and extending maturities. In the latest annual report, management highlighted ongoing integration work following the 3M Food Safety transaction, while fiscal 2025 revenue came in at $894.7 million and operating losses remained elevated, reflecting integration costs and restructuring actions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/711377/000095017025114388/neogen_fy25_annual_repor.pdf))
For francophone investors, NEOG is best viewed as a specialized U.S. healthcare-adjacent industrial technology company with attractive end-markets, but one that is still digesting a transformational acquisition and reshaping its portfolio. SEC Form 4 insider activity and governance disclosures remain relevant monitoring points for market participants following the turnaround. ([neogen.com](https://www.neogen.com/4ac3cb/globalassets/pdfs/quarterly-and-annual-forms/fy2025-q4-10k.pdf))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
